Week in review: RP drug, MIGS device, sensor contacts

• Posted on: Mar 12 2021
• By: Saratoga Opthalmology
• Leave a response

This week, a treatment for retinitis pigmentosa receives orphan drug status, the OMNI platform becomes the first MIGS device cleared for open-angle glaucoma and researchers integrate biosensors into soft contact lenses.
Source: AAO

Posted in: Uncategorized